Bioventus Inc.

NasdaqGS:BVS Stock Report

Market Cap: US$318.5m

Bioventus Future Growth

Future criteria checks 0/6

Bioventus is forecast to grow revenue at 4.7% per annum. EPS is expected to grow by 13.1% per annum.

Key information

n/a

Earnings growth rate

13.1%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth rate5.0%
Future return on equity14.1%
Analyst coverage

Low

Last updated07 May 2024

Recent future growth updates

Recent updates

Bioventus: Bullish On Path To Profitability

Jan 24

Bioventus: Reiterating Buy Thesis Following Q2 Earnings

Sep 08

Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M

Aug 11

Bioventus stock rises as FDA clears SonaStar Elite for use in tumor removal

Aug 03

Bioventus: Strong Value Gap, Insulated Via Leading Market Share

Jun 14

Bioventus: Thoughts After An Active First Year

Mar 29

Bioventus records first commercial shipment of BITS Balance system

Apr 27

Earnings and Revenue Growth Forecasts

NasdaqGS:BVS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026594N/A78571
12/31/2025570N/A51513
12/31/2024543-2458352
12/31/2023512-97815N/A
9/30/2023503-159010N/A
7/1/2023511-224818N/A
4/1/2023514-227-110N/A
12/31/2022512-104-24-14N/A
10/1/2022517-91-15-6N/A
7/2/2022497-19-46N/A
4/2/2022466-161120N/A
12/31/2021431-5923N/A
10/2/2021399-32935N/A
7/3/202137664046N/A
4/3/202132443136N/A
12/31/2020321165572N/A
9/26/2020320167167N/A
6/27/2020316126258N/A
3/28/2020339155554N/A
12/31/201934093841N/A
12/31/2018319-14345N/A
4/2/2016266-23N/A25N/A
12/31/2015254-38N/A19N/A
12/31/2014243-17N/A15N/A
12/31/2013232-26N/A3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if BVS's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if BVS's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if BVS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BVS's revenue (4.7% per year) is forecast to grow slower than the US market (8.3% per year).

High Growth Revenue: BVS's revenue (4.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BVS's Return on Equity is forecast to be low in 3 years time (12.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.